(G) Genpact - Ratings and Ratios

Exchange: NYSE • Country: Bermuda • Currency: USD • Type: Common Stock • ISIN: BMG3922B1072

Outsourcing, Analytics, Consulting, Automation, Finance

G EPS (Earnings per Share)

EPS (Earnings per Share) of G over the last years for every Quarter: "2020-09": 0.56, "2020-12": 0.51, "2021-03": 0.59, "2021-06": 0.66, "2021-09": 0.66, "2021-12": 0.54, "2022-03": 0.6, "2022-06": 0.7, "2022-09": 0.75, "2022-12": 0.7, "2023-03": 0.68, "2023-06": 0.72, "2023-09": 0.76, "2023-12": 0.82, "2024-03": 0.73, "2024-06": 0.72, "2024-09": 0.85, "2024-12": 0.91, "2025-03": 0.84, "2025-06": 0.88, "2025-09": 0.97,

G Revenue

Revenue of G over the last years for every Quarter: 2020-09: 935.523, 2020-12: 950.568, 2021-03: 946.071, 2021-06: 988.126, 2021-09: 1015.737, 2021-12: 1072.277, 2022-03: 1068.443, 2022-06: 1089.147, 2022-09: 1111.037, 2022-12: 1102.545, 2023-03: 1089.319, 2023-06: 1105.524, 2023-09: 1135.792, 2023-12: 1146.253, 2024-03: 1131.237, 2024-06: 1176.212, 2024-09: 1210.949, 2024-12: 1248.741, 2025-03: 1214.926, 2025-06: 1254.418, 2025-09: 1291.257,
Risk via 10d forecast
Volatility 27.8%
Value at Risk 5%th 38.7%
Relative Tail Risk -15.49%
Reward TTM
Sharpe Ratio 0.02
Alpha -12.62
Character TTM
Hurst Exponent 0.669
Beta 0.619
Beta Downside 0.653
Drawdowns 3y
Max DD 35.61%
Mean DD 18.42%
Median DD 20.86%

Description: G Genpact November 03, 2025

Genpact Limited (NYSE:G) is a global provider of business-process outsourcing (BPO) and information-technology services, operating across North America, Latin America, Europe, India and the rest of Asia. The firm is organized into three verticals-Financial Services; Consumer & Healthcare; and High-Tech & Manufacturing-each delivering end-to-end solutions ranging from loan processing and compliance in finance to revenue-cycle management in health care and supply-chain engineering for manufacturers.

Based on FY 2023 results (the latest publicly disclosed figures), Genpact generated roughly **$4.0 billion** in revenue, with an **operating margin of ~12%** and a **year-over-year revenue growth of 12%** driven largely by digital-transformation contracts. The company’s **backlog**-the value of signed but un-delivered work-stood at about **$8 billion**, indicating a multi-year revenue runway. Client concentration remains modest, with the top 10 customers contributing less than **10%** of total revenue, which mitigates single-client risk.

Key macro-economic drivers for Genpact include the accelerating **outsourcing spend in regulated sectors** (especially financial services) as firms seek to meet expanding compliance burdens, and the broader **adoption of AI-enabled automation** that fuels demand for data-tech and CFO advisory services. Additionally, near-shoring trends in North America are prompting enterprises to shift non-core functions to specialized providers like Genpact, supporting a secular growth tail.

For a deeper, data-driven valuation framework, you might explore the detailed metrics on ValueRay.

G Stock Overview

Market Cap in USD 7,670m
Sub-Industry Data Processing & Outsourced Services
IPO / Inception 2007-08-02
Return 12m vs S&P 500 -11.9%
Analyst Rating 3.91 of 5

G Dividends

Dividend Yield 1.86%
Yield on Cost 5y 2.19%
Yield CAGR 5y 11.78%
Payout Consistency 56.9%
Payout Ratio 18.9%

G Growth Ratios

CAGR 3y 2.74%
CAGR/Max DD Calmar Ratio 0.08
CAGR/Mean DD Pain Ratio 0.15
Current Volume 1440.9k
Average Volume 2088.9k

Piotroski VR‑10 (Strict, 0-10) 9.5

Net Income (551.3m TTM) > 0 and > 6% of Revenue (6% = 300.6m TTM)
FCFTA 0.12 (>2.0%) and ΔFCFTA 2.23pp (YES ≥ +1.0pp, WARN ≥ +0.5pp)
NWC/Revenue 14.99% (prev 23.71%; Δ -8.72pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp)
CFO/TA 0.14 (>3.0%) and CFO 729.4m > Net Income 551.3m (YES >=105%, WARN >=100%)
Net Debt (668.0m) to EBITDA (876.9m) ratio: 0.76 <= 3.0 (WARN <= 3.5)
Current Ratio 1.51 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active)
Outstanding Shares last Quarter (176.1m) change vs 12m ago -2.63% (target <= -2.0% for YES)
Gross Margin 35.82% (prev 35.41%; Δ 0.41pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0)
Asset Turnover 93.72% (prev 87.59%; Δ 6.13pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0)
Interest Coverage Ratio 11.32 (EBITDA TTM 876.9m / Interest Expense TTM 69.1m) >= 6 (WARN >= 3)

Altman Z'' 2.94

(A) 0.14 = (Total Current Assets 2.21b - Total Current Liabilities 1.46b) / Total Assets 5.36b
(B) 0.26 = Retained Earnings (Balance) 1.37b / Total Assets 5.36b
(C) 0.15 = EBIT TTM 782.5m / Avg Total Assets 5.34b
(D) 0.20 = Book Value of Equity 552.8m / Total Liabilities 2.82b
Total Rating: 2.94 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D)

ValueRay F-Score (Strict, 0-100) 90.79

1. Piotroski 9.50pt = 4.50
2. FCF Yield 7.74% = 3.87
3. FCF Margin 12.89% = 3.22
4. Debt/Equity 0.55 = 2.35
5. Debt/Ebitda 0.76 = 2.07
6. ROIC - WACC (= 9.08)% = 11.35
7. RoE 22.11% = 1.84
8. Rev. Trend 96.31% = 7.22
9. EPS Trend 87.31% = 4.37

What is the price of G shares?

As of November 15, 2025, the stock is trading at USD 44.89 with a total of 1,440,942 shares traded.
Over the past week, the price has changed by +0.90%, over one month by +12.62%, over three months by +3.13% and over the past year by +1.01%.

Is Genpact a good stock to buy?

Yes, based on ValueRay´s Fundamental Analyses, Genpact (NYSE:G) is currently (November 2025) a good stock to buy. It has a ValueRay Fundamental Rating of 90.79 and therefor a positive outlook according to the companies health.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of G is around 41.44 USD . This means that G is currently overvalued and has a potential downside of -7.69%.

Is G a buy, sell or hold?

Genpact has received a consensus analysts rating of 3.91. Therefore, it is recommended to buy G.
  • Strong Buy: 4
  • Buy: 2
  • Hold: 5
  • Sell: 0
  • Strong Sell: 0

What are the forecasts/targets for the G price?

Issuer Target Up/Down from current
Wallstreet Target Price 50.2 11.8%
Analysts Target Price 50.2 11.8%
ValueRay Target Price 45.6 1.7%

G Fundamental Data Overview November 11, 2025

Market Cap USD = 7.67b (7.67b USD * 1.0 USD.USD)
P/E Trailing = 14.3516
P/E Forward = 18.315
P/S = 1.5312
P/B = 2.7893
P/EG = 1.7
Beta = 0.776
Revenue TTM = 5.01b USD
EBIT TTM = 782.5m USD
EBITDA TTM = 876.9m USD
Long Term Debt = 1.20b USD (from longTermDebt, last fiscal year)
Short Term Debt = 427.3m USD (from shortTermDebt, last quarter)
Debt = 1.41b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 668.0m USD (from netDebt column, last quarter)
Enterprise Value = 8.34b USD (7.67b + Debt 1.41b - CCE 740.8m)
Interest Coverage Ratio = 11.32 (Ebit TTM 782.5m / Interest Expense TTM 69.1m)
FCF Yield = 7.74% (FCF TTM 645.5m / Enterprise Value 8.34b)
FCF Margin = 12.89% (FCF TTM 645.5m / Revenue TTM 5.01b)
Net Margin = 11.01% (Net Income TTM 551.3m / Revenue TTM 5.01b)
Gross Margin = 35.82% ((Revenue TTM 5.01b - Cost of Revenue TTM 3.21b) / Revenue TTM)
Gross Margin QoQ = 36.37% (prev 35.88%)
Tobins Q-Ratio = 1.55 (Enterprise Value 8.34b / Total Assets 5.36b)
Interest Expense / Debt = 0.91% (Interest Expense 12.8m / Debt 1.41b)
Taxrate = 22.98% (43.5m / 189.4m)
NOPAT = 602.6m (EBIT 782.5m * (1 - 22.98%))
Current Ratio = 1.51 (Total Current Assets 2.21b / Total Current Liabilities 1.46b)
Debt / Equity = 0.55 (Debt 1.41b / totalStockholderEquity, last quarter 2.54b)
Debt / EBITDA = 0.76 (Net Debt 668.0m / EBITDA 876.9m)
Debt / FCF = 1.03 (Net Debt 668.0m / FCF TTM 645.5m)
Total Stockholder Equity = 2.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 10.28% (Net Income 551.3m / Total Assets 5.36b)
RoE = 22.11% (Net Income TTM 551.3m / Total Stockholder Equity 2.49b)
RoCE = 21.21% (EBIT 782.5m / Capital Employed (Equity 2.49b + L.T.Debt 1.20b))
RoIC = 16.20% (NOPAT 602.6m / Invested Capital 3.72b)
WACC = 7.12% (E(7.67b)/V(9.08b) * Re(8.30%) + D(1.41b)/V(9.08b) * Rd(0.91%) * (1-Tc(0.23)))
Discount Rate = 8.30% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -2.00%
[DCF Debug] Terminal Value 79.04% ; FCFE base≈596.1m ; Y1≈670.5m ; Y5≈899.8m
Fair Price DCF = 86.13 (DCF Value 14.85b / Shares Outstanding 172.4m; 5y FCF grow 14.47% → 3.0% )
EPS Correlation: 87.31 | EPS CAGR: 12.59% | SUE: 3.02 | # QB: 5
Revenue Correlation: 96.31 | Revenue CAGR: 5.91% | SUE: 1.17 | # QB: 2

Additional Sources for G Stock

News: Wall Street Journal | Benzinga | Yahoo Finance
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle